PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

King’s researchers win £1m grant for COVID-19 research

A research team at King’s College London led by Professor Michael Malim from the School of Immunology & Microbial Sciences has been awarded £1 million funding for research into COVID-19.

The grant, from The Huo Family Foundation, will advance the team’s research into better understanding the immune response to SARS-CoV-2 infection, in the hope of developing better diagnostic testing and novel immunotherapies for patients with virus.

The Foundation will support a programme of work to inform help shape approaches to patient treatment and provide guidance at local and national level on issues of infection surveillance and control.

The University said the multi-disciplinary team, which includes expertise in the immune system and virus-induced diseases, and the clinical diagnosis, management and treatment of infectious diseases, will work alongside the NHS and other academic partners to “rapidly translate scientific breakthroughs to the frontlines of COVID-19 healthcare and infection control”.

“This funding award is essential for us to further develop novel research into COVID-19, expanding on our preliminary work, built on the effort of an incredible team of volunteers and goodwill. We look forward to contributing to the fight against COVID-19, supporting diagnostics and further disease understanding,” said Dr Rocio Martinez-Nunez, from the School of Immunology & Microbial Sciences.

The work so far includes the development of scalable antibody tests to track immunity to the virus and monitoring the human response in patients to understand why people respond differently to the COVID-19 infection.

The team has also set up – in collaboration with Guy’s and St Thomas’ Hospitals and pathology provider Viapath – an NHS-accredited COVID-19 diagnostic centre, recently renamed the June Almeida lab, after the virologist who discovered the first coronavirus in 1964.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026